Related Experiment Video
Updated: Jan 27, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
Published on: January 27, 2023
Monoacylglycerol Lipase Inhibitor Mitigates Severe Acute Pancreatitis in Rats by Modulating the Gut
Tong Su1, Xiaohua Zhang1, Tong Xiao1
1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Weiqi Rd, Jinan 250021, China.
Introduction:
Severe acute pancreatitis (SAP) is characterized by systemic inflammation and gut microbiota dysbiosis. However, the interplay between microbial alterations, host metabolism, and gene expression remains unclear. This study aimed to investigate how monoacylglycerol lipase (MAGL) inhibition by JZL184 alleviates SAP by modulating the gut microbiota- metabolite-target gene network.
Methods:
A rat model of SAP was developed, with rats assigned into three groups for comparison: the Control group (CON), the untreated SAP group (SAP), and the SAP group treated with JZL184 (JZL184). Fecal samples underwent 16S rRNA sequencing to assess microbial diversity and composition. Functional annotation was performed using KEGG pathways. Integrated analyses of intestinal microbiota, metabolomics, and pancreatic transcriptomics (GSE161945) were conducted to construct a microbiota-metabolite-target gene regulatory network, which was validated by qRT-PCR.
Results:
SAP rats exhibited decreased Bacteroidetes, increased Proteobacteria, and enrichment of Escherichia-Shigella. JZL184 treatment restored microbial balance, reducing Escherichia-Shigella and enhancing Lactobacillus and Bacteroides. It also suppressed NOD-like receptor and MAPK signaling pathways. Network analysis revealed positive correlations between Escherichia-Shigella, arachidonic acid, and HMOX1 expression, and negative correlations between Lactobacillus, aspartic acid, and ACE expression. qRT-PCR confirmed normalization of ACE expression in JZL184- treated pancreatic tissues.
Discussion:
JZL184 mitigated SAP by reshaping microbial composition, reducing pro-inflammatory taxa, restoring beneficial microbes, and altering key metabolites. These changes collectively modulated inflammatory pathways, including MAPK and NOD-like receptor signaling. The therapeutic benefit may also be mediated through the microbial control of metabolites that influence gene expression.
Conclusion:
JZL184 effectively mitigates SAP by reshaping the gut microbiota-metabolite-gene network, suppressing pathogenic bacteria and inflammatory pathways while restoring beneficial microbes and metabolic homeostasis. These findings support MAGL inhibition as a promising microbiota- targeted therapeutic strategy for SAP.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Networks
Gene-Environment Interactions